4.6 Review

Linking NLRP3 inflammasome and pulmonary fibrosis: mechanistic insights and promising therapeutic avenues

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Repositioning itraconazole for amelioration of bleomycin-induced pulmonary fibrosis: Targeting HMGB1/TLR4 Axis, NLRP3 inflammasome/NF-κB signaling, and autophagy

Abeer Elkhoely et al.

Summary: This study investigated the potential mitigating effects of itraconazole on bleomycin-induced pulmonary fibrosis and explored the underlying mechanisms. The results showed that itraconazole had significant effects on oxidative stress, inflammation, high-mobility group box 1/toll-like receptor-4 Axis, autophagy, and nuclear factor kappa B/Nod-like receptor protein 3 inflammasome signaling. It also alleviated the histopathological, immunohistochemical, and electron microscopic abnormalities in pulmonary tissues. Therefore, itraconazole may be a promising drug to mitigate the deleterious effects of bleomycin on the lungs.

LIFE SCIENCES (2023)

Article Biochemistry & Molecular Biology

Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation

Guangrui Chen et al.

Summary: This study demonstrated that CEP and PFD effectively suppressed BLM-induced pulmonary fibrosis, alleviated lung tissue inflammation and collagen fiber proliferation, and regulated NF-kappa B/NLRP3 signaling pathway. Therefore, CEP has potential clinical application in the future treatment of pulmonary fibrosis.

MOLECULES (2023)

Article Medicine, Research & Experimental

Mirtazepine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model

Rasha Abdelhady et al.

Summary: The study demonstrates the potential of mirtazapine as a treatment for idiopathic pulmonary fibrosis (IPF), offering both anti-fibrotic effects and improvements in depressive symptoms. This findings provide a platform for the development of a new therapeutic approach for IPF.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Review Food Science & Technology

NLRP3 Inflammasome: A key contributor to the inflammation formation

Wen-Juan Zhang et al.

Summary: Inflammation is a crucial factor in the development of organ diseases, and the NLRP3 inflammasome is the most well-studied inflammasome. The NLRP3 inflammasome is composed of NLRP3, ASC, and pro-caspase-1. It can be activated through classical, non-canonical, and alternative pathways, and its activation is involved in various inflammatory diseases. Factors such as genetics, environment, chemicals, and viral infections can activate the NLRP3 inflammasome and promote inflammation in organs. However, the mechanisms and effects of NLRP3 inflammation in different cells and tissues are still not fully understood.

FOOD AND CHEMICAL TOXICOLOGY (2023)

Article Plant Sciences

Diallyl trisulfide inhibits monosodium urate-induced NLRP3 inflammasome activation via NOX3/4-dependent mitochondrial oxidative stress in RAW 264.7 and bone marrow-derived macrophages

Min Yeong Kim et al.

Summary: This study demonstrates that DATS can suppress MSU-induced inflammation by modulating the NLRP3 pathway and NOX-dependent oxidative stress, highlighting DATS as a potential therapeutic candidate for gouty inflammatory conditions.

PHYTOMEDICINE (2023)

Review Cell & Tissue Engineering

The Role of Lung Resident Mesenchymal Stromal Cells in the Pathogenesis and Repair of Chronic Lung Disease

Declan F. Doherty et al.

Summary: Mesenchymal stromal/stem cells extracted from various tissues, including the lungs, play a crucial role in maintaining pulmonary homeostasis and facilitating repair processes. However, in chronic lung diseases, these lung-resident MSCs (LR-MSCs) undergo changes in their secretory and immunomodulatory properties, contributing to disease pathogenesis. LR-MSCs can also differentiate into myofibroblasts, leading to pulmonary fibrosis. This article reviews the characterization of LR-MSCs and their roles in lung homeostasis/repair and chronic lung disease pathogenesis.

STEM CELLS (2023)

Review Biochemistry & Molecular Biology

Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities

Li-Li Ren et al.

Summary: Fibrosis is the excessive deposition of extracellular matrix components in the processes of tissue repair, causing organ structural integrity and functional impairment. Transforming growth factor-beta (TGF-beta) is a key factor in promoting fibrosis by activating profibrotic signals. This review discusses the role of TGF-beta signaling in fibrotic organs, as well as potential therapeutic options for targeting tissue fibrosis through modulating TGF-beta signaling.

CHEMICO-BIOLOGICAL INTERACTIONS (2023)

Article Environmental Sciences

VX-765 attenuates silica-induced lung inflammatory injury and fibrosis by modulating alveolar macrophages pyroptosis in mice

Huihui Tao et al.

Summary: In this study, it was found that inhibiting inflammatory cell death (pyroptosis) of alveolar macrophages can alleviate silica-induced lung injury and fibrosis, reducing the inflammatory response. These findings provide new insights into the prevention and treatment of early-stage silicosis.

ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2023)

Review Biochemistry & Molecular Biology

Mechanisms of NLRP3 inflammasome- mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis

Harsh Vardhan Charan et al.

Summary: Liver injury induces an inflammatory response, leading to the activation of hepatic stellate cells (HSCs) that secrete ECM proteins and promote liver fibrosis. Inflammasomes, which are cytoplasmic protein complexes, mediate exaggerated inflammatory immune responses and contribute to chronic liver diseases. They recognize microbial motifs and damage-associated molecular patterns, leading to the production of active cytokines. This review provides a comprehensive summary of the role of NLRP3 inflammasome in liver fibrosis and discusses potential strategies for inhibiting its activation and downstream signaling.

GENES & DISEASES (2023)

Review Pathology

Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis

Benjamin J. Moss et al.

Summary: The pathogenesis of idiopathic pulmonary fibrosis (IPF) involves a complex interplay of various cell types and signaling pathways. Novel bioinformatics tools can help discover disease pathways, cell-specific mechanisms, and cell-cell interactions.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)

Review Pharmacology & Pharmacy

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis

Qianru Mei et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited understanding of its pathogenesis. Recent studies suggest that sustained lung epithelial injury and fibroblast differentiation play key roles in the development of IPF. Current treatments can slow disease progression but cannot cure it.

FRONTIERS IN PHARMACOLOGY (2022)

Article Engineering, Biomedical

Nanoformulation of a carbon monoxide releasing molecule protects against cyclosporin A-induced nephrotoxicity and renal fibrosis via the suppression of the NLRP3 inflammasome mediated TGF-β/Smad pathway

Zhengmei Xia et al.

Summary: In this study, the researchers explored the potential and usefulness of SMA/CORM2, a nano-drug delivery system for carbon monoxide, in treating CsA-induced renal fibrosis. They found that SMA/CORM2 significantly ameliorated the kidney injuries and fibrosis caused by CsA by suppressing the activation of the NLRP3 inflammasome and downregulating the TGF beta/Smad signaling pathway. These findings suggest that SMA/CORM2 has therapeutic potential for CsA-induced renal fibrosis and other inflammatory diseases.

ACTA BIOMATERIALIA (2022)

Review Pathology

The Inflammasome NLR Family Pyrin Domain-Containing Protein 3 (NLRP3) as a Novel Therapeutic Target for Idiopathic Pulmonary Fibrosis

Ruben M. L. Colunga Biancatelli et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is an incurable disease and current medications can only slow down disease progression, highlighting the importance of exploring novel therapeutic approaches. The overactivation of NLRP3 in IPF patients has been linked to chronic lung injury and fibrosis development.

AMERICAN JOURNAL OF PATHOLOGY (2022)

Article Immunology

Galectin-3 regulates microglial activation and promotes inflammation through TLR4/MyD88/NF-kB in experimental autoimmune uveitis

Yusen Liu et al.

Summary: This study investigated the effect and mechanism of Galectin-3 on microglial activation and inflammation in autoimmune uveitis. The results showed that the expression of Galectin-3 was increased in microglia of uveitis retinas. Inhibition of Galectin-3 improved the clinical and pathological manifestations of uveitis and reduced the expression of proinflammatory factors. The mechanism involved down-regulation of TLR4 and MyD88 expression and inhibition of NF-kappa B p65 activation in microglia.

CLINICAL IMMUNOLOGY (2022)

Review Biochemistry & Molecular Biology

Targeting TGF-β signal transduction for fibrosis and cancer therapy

Dandan Peng et al.

Summary: TGF-beta plays essential roles in early embryonic development, organogenesis, immune regulation, tissue repair, and adult homeostasis. Its involvement in fibrosis and cancer is complex and context-dependent, showing both inhibitory and promoting effects. Therapeutics targeting TGF-beta signaling hold promise in treating fibrosis and cancer, although the development is hindered by potential systemic cytotoxicity.

MOLECULAR CANCER (2022)

Article Multidisciplinary Sciences

Activation of NLRP3 inflammasome in stable chronic obstructive pulmonary disease

Ivona Markelic et al.

Summary: The activation of NLRP3 inflammasome, as indicated by increased expression levels of IL1B, NLRP3, CASP1 and elevated IL-1 beta concentration, is observed in patients with stable COPD, suggesting its involvement in the pathogenesis and chronic inflammation of COPD.

SCIENTIFIC REPORTS (2022)

Article Cell Biology

L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis

Hemant Joshi et al.

Summary: The actin-bundling protein L-plastin (LPL) plays a crucial role in the activation of the NLRP3 inflammasome, which is involved in IL-1 beta production. LPL stabilizes the interactions between ASC and the kinase Pyk2, enabling ASC oligomerization during NLRP3 assembly.

CELL REPORTS (2022)

Article Pharmacology & Pharmacy

ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation

Dongxin Chen et al.

Summary: This study investigated the effects of a selective CB1R agonist, ACPA, on pulmonary fibrosis induced by bleomycin (BLM). The results showed that ACPA treatment significantly improved survival rate and alleviated pulmonary fibrosis in BLM-treated mice. ACPA inhibited the expressions of extracellular matrix markers and diminished fibroblast migration triggered by TGF-beta. Furthermore, ACPA reduced the activation of TGF-beta-Smad2/3 signaling and decreased the expressions of downstream effector proteins in TGF-beta-challenged primary lung fibroblasts. These findings suggest that ACPA exhibits antifibrotic efficacy by targeting CB1R and inhibiting TGF-beta-Smad2/3 signaling.

FRONTIERS IN PHARMACOLOGY (2022)

Review Biochemistry & Molecular Biology

The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis

Carol M. Artlett

Summary: Fibrosis is the end result of chronic inflammation, characterized by excessive extracellular matrix deposition. The NLRP3 inflammasome plays a significant role in the pathogenesis of fibrotic disease and its activation leads to the secretion of pro-inflammatory cytokines and the formation of fibrotic tissue. The activation of NLRP3 is controlled by multiple activators and involves complex regulatory mechanisms.

BIOMOLECULES (2022)

Review Biochemistry & Molecular Biology

Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?

Elena Ortiz-Zapater et al.

Summary: Fibrosis in the lungs is a growing clinical problem that leads to shortness of breath and respiratory failure. It can be caused by various diseases such as idiopathic pulmonary fibrosis, asthma, COPD, allergies, and infection clearance. This review discusses the different types of fibrosis, the main cells involved, and the mechanisms of fibrosis. It also highlights current treatments and potential targets for anti-fibrotic therapies.

BIOMEDICINES (2022)

Review Medicine, Research & Experimental

Deciphering the role of damage-associated molecular patterns and inflammatory responses in acute lung injury

Po-Chun Hsieh et al.

Summary: Acute lung injury (ALI) is a highly fatal disease characterized by diffuse pulmonary infiltrates. Damage-associated molecular patterns (DAMPs) play a crucial role in the initiation and progression of ALI. Proinflammatory cytokine overproduction, cell death, destruction of alveoli-endothelial barriers, and neutrophil infiltration are the main features of ALI. Alveolar macrophages (AMs), neutrophils, and epithelial cells (AECs) are important players in the pathogenesis of ALI.

LIFE SCIENCES (2022)

Review Respiratory System

Alveolar Epithelial Type 2 Cell Dysfunction in Idiopathic Pulmonary Fibrosis

Weiwei Zhu et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible pulmonary disease with unclear pathogenesis and limited treatment options. Dysfunction of alveolar epithelial type 2 (AT2) cells is associated with the development of IPF, involving senescence, apoptosis, stress, damage, and metabolic reprogramming. Potential treatments targeting AT2 cell dysfunction are summarized.
Review Immunology

Activation and regulation mechanisms of NOD-like receptors based on structural biology

Umeharu Ohto

Summary: Innate immunity is a crucial defense mechanism against microbial infections. Innate immune pattern recognition receptors (PRRs) play significant roles in detecting invading pathogens and activating the immune response. Cellular components and pathogen-associated molecular patterns (PAMPs) can trigger inflammatory responses and activate the immune system. Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) constitute a major family of intracellular PRRs and are involved in various diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Article Respiratory System

Transcriptional inhibition of miR-486-3p by BCL6 upregulates Snail and induces epithelial-mesenchymal transition during radiation-induced pulmonary fibrosis

Ziyan Yan et al.

Summary: This study reveals that ionizing radiation (IR) induces pulmonary fibrosis by altering the content of miR-486-3p and inducing epithelial mesenchymal transition (EMT). IR decreases the levels of miR-486-3p, which is closely related to the occurrence of radiation-induced pulmonary fibrosis (RIPF). The transcription factor BCL6 is activated by IR, inhibiting the transcription of miR-486-3p and decreasing its content, which in turn increases the content of the target gene slug and triggers EMT.

RESPIRATORY RESEARCH (2022)

Article Gastroenterology & Hepatology

Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis

Susanne Gaul et al.

Summary: The study found that hepatocyte pyroptosis, caused by NLRP3 inflammasome activation, leads to the release of inflammasome proteins and exacerbates fibrogenesis. Inhibition of caspase-1 and gasdermin D activation can prevent pyroptosis. The released inflammasomes are taken up by hepatic stellate cells, promoting inflammation and fibrosis. These findings suggest a novel mechanism for liver injury and potential therapeutic targets for chronic liver diseases.

JOURNAL OF HEPATOLOGY (2021)

Article Medicine, Research & Experimental

Astragaloside IV alleviates silica-induced pulmonary fibrosis via inactivation of the TGF-β1/Smad2/3 signaling pathway

Nannan Li et al.

Summary: The study demonstrated that ASV has anti-fibrotic effects in silicosis rats by reducing inflammation and oxidative stress, and inhibiting the TGF-beta 1/Smad signaling pathway. This suggests that ASV may prevent silicosis-induced fibrosis by regulating key pathways involved in the progression of pulmonary fibrosis.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Review Chemistry, Multidisciplinary

NOD-like receptors in autoimmune diseases

Li Chen et al.

Summary: Autoimmune diseases are characterized by dysregulation of the immune system, with NLRs playing essential roles in various diseases. NLR proteins recognize specific molecular patterns to regulate immune response pathways.

ACTA PHARMACOLOGICA SINICA (2021)

Article Environmental Sciences

Snail-mediated partial epithelial mesenchymal transition augments the differentiation of local lung myofibroblast

Yan Wang et al.

Summary: The study revealed that partial EMT may be involved in the development of pulmonary fibrosis diseases, with Snail playing a critical role in the process. The process of EMT in epithelial cells promoted the differentiation of lung myofibroblasts, and this epithelial-mesenchymal crosstalk was mainly controlled by Snail.

CHEMOSPHERE (2021)

Review Medicine, General & Internal

Interleukin-18 in Inflammatory Kidney Disease

Yasuaki Hirooka et al.

Summary: IL-18 is a pro-inflammatory cytokine structurally similar to IL-1 beta, promoting Th1 response and IFN-γ production. Inflammatory diseases may lead to an imbalance in IL-18 activity, with insufficient neutralization by IL-18BP.

FRONTIERS IN MEDICINE (2021)

Article Biochemistry & Molecular Biology

NLRP3 inflammasome activation in alveolar epithelial cells promotes myofibroblast differentiation of lung-resident mesenchymal stem cells during pulmonary fibrogenesis

Jie Ji et al.

Summary: The activation of NLRP3 inflammasome is elevated in fibrotic lungs, contributing to a better understanding of the pathogenesis of pulmonary fibrosis and revealing a potential therapeutic strategy for disorders associated with pulmonary fibrosis.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Review Immunology

The inflammatory speech of fibroblasts

Ronen Schuster et al.

Summary: Activation of fibroblasts is crucial for tissue repair and fibrosis, with novel tools revealing their heterogeneous nature within a larger population of overlapping cell types. Activated fibroblasts exhibit various functions and their understanding is vital for targeted intervention in fibroproliferative and fibrocontractive disorders.

IMMUNOLOGICAL REVIEWS (2021)

Review Medicine, Research & Experimental

TGF-β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review)

Zhimin Ye et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a global disease with no effective treatment currently available. Research shows that transforming growth factor-beta 1 (TGF-beta 1) plays a crucial role in the development of IPF, promoting fibrosis through various signaling pathways and affecting oxidative stress and epigenetics. Although most processes related to TGF-beta 1 promote IPF, it can also inhibit its development.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Review Cell Biology

Pyroptosis: Mechanisms and Links with Fibrosis

Zihao Song et al.

Summary: Fibrosis is a major global healthcare burden responsible for approximately 45% of deaths in the industrialized world. Recent studies indicate that inflammation and pyroptosis play significant roles in fibrosis and could serve as potential targets for antifibrotic therapies.

CELLS (2021)

Review Medicine, Research & Experimental

Toll-like receptor 4: An attractive therapeutic target for acute kidney injury

Ankush Kumar Jha et al.

Summary: This review emphasizes the role of TLR4 signaling pathway in AKI and highlights potential compounds of natural and synthetic origin that can avert renal TLR4 signaling and offer protection against AKI in preclinical models. Targeting TLR4 and its downstream effectors could serve as an effective therapeutic intervention to prevent renal inflammation and subsequent kidney damage.

LIFE SCIENCES (2021)

Article Pharmacology & Pharmacy

Resistin induces cardiac fibroblast-myofibroblast differentiation through JAK/STAT3 and JNK/c-Jun signaling

Rajvir Singh et al.

Summary: This study reveals the role of resistin in cardiac fibrosis, promoting fibroblast-to-myofibroblast differentiation through JAK/STAT3 and JNK/c-Jun pathways, independent of TGF beta 1. Resistin-null mice showed improvements in cardiac function and reduction in tissue fibrosis, indicating the potential stimulation of cardiac fibrosis by resistin.

PHARMACOLOGICAL RESEARCH (2021)

Article Oncology

Andrographolide alleviates bleomycin-induced NLRP3 inflammasome activation and epithelial-mesenchymal transition in lung epithelial cells by suppressing AKT/mTOR signaling pathway

Jingpei Li et al.

Summary: The study demonstrated that Andro can alleviate bleomycin-induced pulmonary fibrosis by suppressing NLRP3 inflammasome activation and epithelial-mesenchymal transition.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Review Pharmacology & Pharmacy

Targeting the gasdermin D as a strategy for ischemic stroke therapy

Jiabing Wang et al.

Summary: Stroke, a major cause of death and disability, leads to neuroinflammation which can be targeted for therapeutic interventions. Pyroptosis, a form of programmed cell death, involves GSDMD as a key player in triggering inflammatory responses and cell death in ischemic stroke. Understanding the role of GSDMD may provide new insights for novel therapeutic strategies.

BIOCHEMICAL PHARMACOLOGY (2021)

Review Immunology

NLRP3 inflammasome activation and cell death

Yi Huang et al.

Summary: The NLRP3 inflammasome is a cytosolic multiprotein complex that responds to microbial infection, endogenous danger signals, and environmental stimuli. Its activation can induce pyroptosis and release of inflammatory cytokines, contributing to innate immune defense. However, aberrant activation of the NLRP3 inflammasome is associated with inflammatory diseases, and there is a close relationship between cell death pathways and NLRP3 inflammasome activation.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Integrative & Complementary Medicine

Danggui Buxue Tang Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing the TLR4/NLRP3 Signaling Pathway in Rats

Jiepeng Wang et al.

Summary: Danggui Buxue Tang (DBT) has a significant inhibitory effect on pulmonary fibrosis in rats, reducing pathological changes by decreasing the secretion of inflammatory cytokines and collagen deposition. The study found that DBT may inhibit fibrosis by suppressing the TLR4/MyD88/NF-kappa B signaling pathway and the NLRP3/ASC/caspase-1 axis.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2021)

Article Immunology

Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats

Yongcan Wu et al.

Summary: Pre-treatment with PLD alleviates lung inflammation and injury induced by LPS, reduces inflammatory cytokine levels, modulates oxidative stress-related factors in lung tissue, and inhibits the activation of NLRP3 and NF-kappa B signaling pathway.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Immunology

Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathways

Yue Xiong et al.

Summary: DHL treatment effectively alleviated BLM-induced pulmonary fibrosis and inflammation by reducing pro-fibrotic mediators, inhibiting inflammatory cell infiltration, and downregulating IL-33 expression. The mechanism involved the JNK/p38 MAPK-mediated NF-kappa B signaling pathway to suppress macrophage activation and decrease IL-13 and TGF-beta levels.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms

Paula Montero et al.

Summary: This review explores the activation of the JAK/STAT molecular pathway in ILDs and its impact on cellular fibrotic processes, highlighting the significant role of JAK/STAT in ILDs. It also discusses the potential therapeutic drugs targeting JAK/STAT and their application in vitro and in clinical trials.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Gastroenterology & Hepatology

Role of the inflammasome, gasdermin D, and pyroptosis in non-alcoholic fatty liver disease

Itzayana Rodriguez-Antonio et al.

Summary: Pyroptosis is a type of programmed cell death mediated by the inflammasome through the pro-inflammatory activity of gasdermin D. Research indicates that gasdermin D plays a crucial role in connecting an elevated immune response to a sustained inflammation, linking it to the progression of non-alcoholic fatty liver disease to non-alcoholic steatohepatitis. Both basic and clinical studies show evidence supporting gasdermin D as a potential therapeutic target for diseases characterized by perpetuated inflammatory processes.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Multidisciplinary Sciences

IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis

Yu Nakanishi et al.

Summary: The study indicates that interleukin-18 binding protein can serve as a diagnostic and prognostic biomarker for idiopathic pulmonary fibrosis. Serum interleukin-18 binding protein levels are independently associated with the disease and can predict the prognosis of idiopathic pulmonary fibrosis, showing a positive correlation with the extent of fibrosis.

PLOS ONE (2021)

Review Cell Biology

Monocyte and macrophage derived myofibroblasts: Is it fate? A review of the current evidence

Megan Vierhout et al.

Summary: Research has shown the existence of macrophage-myofibroblast transition (MMT) in various systems, suggesting it could potentially occur in all fibrotic conditions and constitute a reasonable therapeutic target. Evidence supporting MMT includes co-expression of macrophage and myofibroblast markers, as well as fate-mapping experiments in murine models. Further understanding of circulating precursors and molecular mechanisms governing MMT could lead to the development of novel antifibrotic therapies.

WOUND REPAIR AND REGENERATION (2021)

Article Immunology

Inhibition of the Inflammasome Activity of NLRP3 Attenuates HDM-Induced Allergic Asthma

Ming Ma et al.

Summary: Inhaled allergens promote activation of NLRP3 inflammasome, leading to allergic asthma. The study found that NLRP3 in alveolar macrophages plays a role in promoting the development of allergic asthma through an inflammasome-dependent mechanism. Targeting the NLRP3 inflammasome with small molecules may offer new treatment options for this disease.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Inflammasomes and Fibrosis

Wen-Juan Zhang et al.

Summary: Fibrosis is the final common pathway of inflammatory diseases in various organs, and inflammasomes, especially NLRP3, play a crucial role in this process. Inflammasomes can be activated through classical and non-classical pathways, with the former being better understood.

FRONTIERS IN IMMUNOLOGY (2021)

Review Cell & Tissue Engineering

The bright side of fibroblasts: molecular signature and regenerative cues in major organs

Rita N. Gomes et al.

Summary: Fibrosis is a pathological process characterized by tissue replacement with extracellular matrix, but fibroblasts have been found to play a pro-regenerative role in different organs by maintaining stem cell niches or promoting cell adhesion, migration, and proliferation through secreted molecules.

NPJ REGENERATIVE MEDICINE (2021)

Review Biochemistry & Molecular Biology

Pattern recognition receptors in health and diseases

Danyang Li et al.

Summary: Pattern recognition receptors (PRRs) are a class of receptors that can directly recognize specific molecular structures on pathogens, apoptotic host cells, and damaged senescent cells, bridging nonspecific immunity and specific immunity. Through the recognition and binding of ligands, PRRs can produce immunoprotective effects against infections and tumors. Research on PRRs and their ligands has greatly enhanced understanding of the signaling pathways involved, providing insights for the treatment of immune-related diseases and tumors.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Chemistry, Medicinal

Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases

Jin Kyung Seok et al.

Summary: Inflammasomes are critical cytosolic receptors that play key roles in immunity and tissue repair. The NLRP3 inflammasome is well-known for its involvement in inflammatory diseases and efforts are being made to develop therapeutic applications targeting it. Small molecule inhibitors are being developed to provide new opportunities for treating NLRP3 inflammasome-related diseases.

ARCHIVES OF PHARMACAL RESEARCH (2021)

Review Cell Biology

Alveolar and lung interstitial macrophages: Definitions, functions, and roles in lung fibrosis

Ting Shi et al.

Summary: Lung M phi s are the main innate immune cells in the lung, playing important roles in host defense and immune regulation during homeostasis. Alveolar M phi s (AMs) and interstitial M phi s (IMs) are two subsets of lung M phi s, distinguished by their locations and endowed with distinct features and plasticity based on their origins and immunological microenvironment. This review discusses the latest definitions and functions of lung M phi s at homeostasis and highlights their divergent roles in lung fibrosis.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Review Immunology

The complex interplay between endoplasmic reticulum stress and the NLRP3 inflammasome: a potential therapeutic target for inflammatory disorders

Wai Chin Chong et al.

Summary: Inflammation is a complex immune response essential for protection and tissue healing, but dysregulation can lead to inflammatory diseases. Endoplasmic reticulum stress and inflammasomes play crucial roles in activating inflammatory pathways, with the former potentially exacerbating the latter, suggesting new therapeutic targets for inflammatory disorders.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis

Chang-Mei Weng et al.

BIOSCIENCE REPORTS (2020)

Review Rheumatology

Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases

Boris Hinz et al.

NATURE REVIEWS RHEUMATOLOGY (2020)

Article Biochemistry & Molecular Biology

Pericyte-myofibroblast transition in the human lung

Miki Yamaguchi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Review Immunology

The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis

Amani Abraheem Alsadiq Alyaseer et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Respiratory System

Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis

Archana Vijay Gaikwad et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)

Review Biochemistry & Molecular Biology

NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways

Jaye M. Platnich et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)

Review Biochemistry & Molecular Biology

The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation

Rhiannon Campden et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)

Review Biochemistry & Molecular Biology

NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer

Fernando J. Velloso et al.

BIOSCIENCE REPORTS (2019)

Article Oncology

The Hsp27-Mediated IkBα-NFκB Signaling Axis Promotes Radiation-Induced Lung Fibrosis

Jee-Youn Kim et al.

CLINICAL CANCER RESEARCH (2019)

Review Integrative & Complementary Medicine

Diverse Pharmacological Activities and Potential Medicinal Benefits of Geniposide

Yan-Xi Zhou et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)

Review Pharmacology & Pharmacy

MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies

Gulcin Tezcan et al.

FRONTIERS IN PHARMACOLOGY (2019)

Review Biochemistry & Molecular Biology

Structure, interactions and self-assembly of ASC-dependent inflammasomes

Eva de Alba

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)

Review Immunology

Structural Basis of IL-1 Family Cytokine Signaling

James K. Fields et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Pharmacology & Pharmacy

Raltegravir Attenuates Experimental Pulmonary Fibrosis In Vitro and In Vivo

Xue Zhang et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Biochemistry & Molecular Biology

Fibrocytes and fibroblasts-Where are we now

Sy Giin Chong et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition

Li-Ming Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Review Biochemistry & Molecular Biology

Intestinal fibrosis

Marco Vincenzo Lenti et al.

MOLECULAR ASPECTS OF MEDICINE (2019)

Article Respiratory System

YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells

Chuyi Zhang et al.

RESPIRATORY RESEARCH (2019)

Review Immunology

A pathologic two-way street: how innate immunity impacts lung fibrosis and fibrosis impacts lung immunity

Helen Warheit-Niemi et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)

Review Immunology

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Karen V. Swanson et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Review Immunology

Interleukin-18: Biological properties and role in disease pathogenesis

Gilles Kaplanski

IMMUNOLOGICAL REVIEWS (2018)

Article Biochemistry & Molecular Biology

The big five in fibrosis: Macrophages, myofibroblasts, matrix, mechanics, and miscommunication

Pardis Pakshir et al.

MATRIX BIOLOGY (2018)

Review Biotechnology & Applied Microbiology

Targeting the NLRP3 inflammasome in inflammatory diseases

Matthew S. J. Mangan et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Article Multidisciplinary Sciences

Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis

Karim C. El Kasmi et al.

NATURE COMMUNICATIONS (2018)

Article Pharmacology & Pharmacy

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition

Sun Young Kyung et al.

BMC PHARMACOLOGY & TOXICOLOGY (2018)

Review Cell Biology

TGF-β receptors: In and beyond TGF-β signaling

Alexandra Vander Ark et al.

CELLULAR SIGNALLING (2018)

Article Environmental Sciences

NLRP3 inflammasome activation and lung fibrosis caused by airborne fine particulate matter

Runxiao Zheng et al.

ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2018)

Article Multidisciplinary Sciences

NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway

Iva Hafner-Bratkovic et al.

NATURE COMMUNICATIONS (2018)

Review Medicine, General & Internal

The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis

Omkar Desai et al.

FRONTIERS IN MEDICINE (2018)

Review Pharmacology & Pharmacy

Purinergic receptors: new targets for the treatment of gout and fibrosis

Thomas Gicquel et al.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)

Article Oncology

NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis

Rui Tian et al.

EXPERIMENTAL CELL RESEARCH (2017)

Review Biochemistry & Molecular Biology

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

Jianjin Shi et al.

TRENDS IN BIOCHEMICAL SCIENCES (2017)

Review Cell Biology

Gasdermins: Effectors of Pyroptosis

Stephen B. Kovacs et al.

TRENDS IN CELL BIOLOGY (2017)

Article Medicine, General & Internal

Idiopathic pulmonary fibrosis

Fernando J. Martinez et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Review Biochemistry & Molecular Biology

CITA/NLRC5: A critical transcriptional regulator of MHC class I gene expression

Isaac Downs et al.

BIOFACTORS (2016)

Editorial Material Biochemistry & Molecular Biology

The killer protein Gasdermin D

John A. Wright et al.

CELL DEATH AND DIFFERENTIATION (2016)

Article Medicine, Research & Experimental

Interleukin-18 deficiency protects against renal interstitial fibrosis in aldosterone/salt-treated mice

Akiko Tanino et al.

CLINICAL SCIENCE (2016)

Review Urology & Nephrology

TGF-β: the master regulator of fibrosis

Xiao-ming Meng et al.

NATURE REVIEWS NEPHROLOGY (2016)

Review Biochemistry & Molecular Biology

Mechanism and Regulation of NLRP3 Inflammasome Activation

Yuan He et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Article Oncology

JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers

Jos L. J. van der Velden et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2016)

Review Physiology

NOD-LIKE RECEPTORS: VERSATILE CYTOSOLIC SENTINELS

Vinicius Motta et al.

PHYSIOLOGICAL REVIEWS (2015)

Article Pharmacology & Pharmacy

NLRP3 inflammasome and its inhibitors: a review

Bo-Zong Shao et al.

FRONTIERS IN PHARMACOLOGY (2015)

Review Biochemistry & Molecular Biology

Mechanisms and Functions of Inflammasomes

Mohamed Lamkanfi et al.

Article Respiratory System

Elevated expression of the NLRP3 inflammasome in neutrophilic asthma

Jodie L. Simpson et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Review Cell Biology

Molecular mechanisms of epithelial-mesenchymal transition

Samy Lamouille et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)

Article Multidisciplinary Sciences

Activation of NLRP3 inflammasome by crystalline structures via cell surface contact

Aswin Hari et al.

SCIENTIFIC REPORTS (2014)

Review Immunology

NLRC5, at the heart of antigen presentation

Andreas Neerincx et al.

FRONTIERS IN IMMUNOLOGY (2013)

Review Immunology

Functions of NOD-like receptors in human diseases

Yifei Zhong et al.

FRONTIERS IN IMMUNOLOGY (2013)

Review Immunology

Activation and regulation of the inflammasomes

Eicke Latz et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Article Biochemistry & Molecular Biology

MEK-ERK Pathway Modulation Ameliorates Pulmonary Fibrosis Associated with Epidermal Growth Factor Receptor Activation

Satish K. Madala et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)

Article Respiratory System

A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice

Akihiro Takemasa et al.

EUROPEAN RESPIRATORY JOURNAL (2012)

Article Immunology

Activation of the NLRP3 Inflammasome by Group B Streptococci

Alessandro Costa et al.

JOURNAL OF IMMUNOLOGY (2012)

Article Immunology

NLRC5: a key regulator of MHC class I-dependent immune responses

Koichi S. Kobayashi et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Review Biochemistry & Molecular Biology

Understanding the mechanism of IL-1β secretion

Gloria Lopez-Castejon et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2011)

Review Immunology

Sensing damage by the NLRP3 inflammasome

Jaklien C. Leemans et al.

IMMUNOLOGICAL REVIEWS (2011)

Article Critical Care Medicine

Extracellular ATP Is a Danger Signal Activating P2X7 Receptor in Lung Inflammation and Fibrosis

Nicolas Riteau et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Article Critical Care Medicine

Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis

Thomas H. Sisson et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Editorial Material Cell Biology

Nod proteins link bacterial sensing and autophagy

Leonardo H. Travassos et al.

AUTOPHAGY (2010)

Review Biochemistry & Molecular Biology

The Inflammasomes

Kate Schroder et al.

Article Pharmacology & Pharmacy

ATP and the pathogenesis of COPD

Esmaeil Mortaz et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2010)

Article Biochemistry & Molecular Biology

Neuronal apoptosis inhibitory protein, NAIP, is an inhibitor of procaspase-9

Jamshid Davoodi et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)

Article Cell Biology

Snail More than EMT

Yadi Wu et al.

CELL ADHESION & MIGRATION (2010)

Article Pathology

Disruption of Interleukin-1 Signaling Improves the Quality of Wound Healing

Alan A. Thomay et al.

AMERICAN JOURNAL OF PATHOLOGY (2009)

Article Critical Care Medicine

Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis

Pamela Gasse et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)

Article Biochemistry & Molecular Biology

Role of Proinflammatory Cytokines IL-18 and IL-1β in Bleomycin-Induced Lung Injury in Humans and Mice

Tomoaki Hoshino et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)

Review Immunology

Function of Nod-like receptors in microbial recognition and host defense

Luigi Franchi et al.

IMMUNOLOGICAL REVIEWS (2009)

Article Immunology

IL-1R1/MyD88 Signaling Is Critical for Elastase-Induced Lung Inflammation and Emphysema

Isabelle Couillin et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Transplantation

Interleukin-1 beta regulates proximal tubular cell transforming growth factor beta-1 signalling

Dong Dong Luo et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)

News Item Biochemistry & Molecular Biology

Putting the kibosh on mitochondrial antiviral signaling

Robert P. Kruger

Article Cell Biology

The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner

Alessandro Sorrentino et al.

NATURE CELL BIOLOGY (2008)

Article Multidisciplinary Sciences

The Nod-Like Receptor (NLR) Family: A Tale of Similarities and Differences

Martina Proell et al.

PLOS ONE (2008)

Article Multidisciplinary Sciences

NLRX1 is a regulator of mitochondrial antiviral immunity

Chris B. Moore et al.

NATURE (2008)

Article Medicine, Research & Experimental

IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice

Pamela Gasse et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Biochemistry & Molecular Biology

TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA

Matt K. Lee et al.

EMBO JOURNAL (2007)

Review Cell Biology

Therapies for bleomycin induced lung fibrosis through regulation of TGF-β1 induced collagen gene expression

Kenneth R. Cutroneo et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2007)

Article Multidisciplinary Sciences

Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling

Joseph A. Duncan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Pathology

Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis

Felix Chua et al.

AMERICAN JOURNAL OF PATHOLOGY (2007)

Review Cell Biology

Unraveling signalling cascades for the Snail family of transcription factors

B De Craene et al.

CELLULAR SIGNALLING (2005)

Article Biochemistry & Molecular Biology

Interleukin-1β causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung

U Lappalainen et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)

Article Biochemistry & Molecular Biology

Enhanced expression of interleukin-18 and its receptor in idiopathic pulmonary fibrosis

Y Kitasato et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)

Article Immunology

PYNOD, a novel Apaf-1/CED4-like protein is an inhibitor of ASC and caspase-1

YT Wang et al.

INTERNATIONAL IMMUNOLOGY (2004)

Article Biochemistry & Molecular Biology

IAP suppression of apoptosis involves distinct mechanisms: The TAK1/JNK1 signaling cascade and caspase inhibition

MG Sanna et al.

MOLECULAR AND CELLULAR BIOLOGY (2002)